Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Mohammad M. Al-Sanea, Tamer M. Nasr, Samir Bondock, Aya Y. Gawish & Nada M. Mohamed. (2023) Design, synthesis and cytotoxic evaluation of novel bis-thiazole derivatives as preferential Pim1 kinase inhibitors with in vivo and in silico study. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Jian Wang, Ya-Dong Chen, Hai-Chun Liu, Guo-Wu Lin, Tao-Tao Yang, Hao-Liang Yuan, Ting Ran, Shuai Lu, Wei-Wei Zhang, Ying Leng & Tao Lu. (2011)
De novo design of quinazoline derivatives as CDK2 inhibitors: 3D-QSAR, molecular fragment replacement and Volsurf predictions. Molecular Simulation 37:10, pages 824-836.
Read now
Read now
B. K. Sharma, S. K. Sharma, P. Singh & Susheela Sharma. (2008) A quantitative structure-activity relationship study of novel, potent, orally active, selective VEGFR-2 and PDGFRα tyrosine kinase inhibitors: Derivatives of N-Phenyl-N′-{4-(4-quinolyloxy)phenyl}urea as antitumor agents. Journal of Enzyme Inhibition and Medicinal Chemistry 23:2, pages 168-173.
Read now
Read now
Richard D Connell. (2003) The 2-oxindole chemotype and patent activity inspired by the SU5416 franchise. Expert Opinion on Therapeutic Patents 13:6, pages 737-749.
Read now
Read now
Richard D Connell. (2002) Patent focus on cancer chemotherapeutics V. Angiogenesis agents: September 2001 – August 2002. Expert Opinion on Therapeutic Patents 12:12, pages 1763-1782.
Read now
Read now
Richard D Connell & Jean S Beebe. (2001) Patent focus on cancer chemotherapeutics. IV Angiogenesis agents: April 2001 - August 2001. Expert Opinion on Therapeutic Patents 11:12, pages 1919-1945.
Read now
Read now
. (2001) Amide derivatives useful for the treatment of diseases mediated by cytokines. Expert Opinion on Therapeutic Patents 11:9, pages 1471-1473.
Read now
Read now
Tomi Sawyer, Brendan Boyce, David Dalgarno & John Iuliucci. (2001) Src inhibitors: genomics to therapeutics. Expert Opinion on Investigational Drugs 10:7, pages 1327-1344.
Read now
Read now
Richard D Connell & Jean S Beebe. (2001) Patent focus on cancer chemotherapeutics. III Angiogenesis agents: October 2000 – March 2001. Expert Opinion on Therapeutic Patents 11:7, pages 1171-1203.
Read now
Read now
Articles from other publishers (54)
Tanuja T. Yadav, Manikanta Murahari, G.J. Peters & Mayur YC. (2022) A comprehensive review on acridone based derivatives as future anti-cancer agents and their structure activity relationships. European Journal of Medicinal Chemistry 239, pages 114527.
Crossref
Crossref
Thanh-Diep Ly, Ricarda Plümers, Bastian Fischer, Vanessa Schmidt, Doris Hendig, Joachim Kuhn, Cornelius Knabbe & Isabel Faust. (2020) Activin A-Mediated Regulation of XT-I in Human Skin Fibroblasts. Biomolecules 10:4, pages 609.
Crossref
Crossref
Shang Gao, Chi Yang, Yue Huang, Lei Zhao, Xiaoming Wu, Hequan Yao & Aijun Lin. (2016)
Pd(
ii
)-catalyzed intramolecular oxidative Heck dearomative reaction: approach to thiazole-fused pyrrolidinones with a C2-azaquarternary center
. Organic & Biomolecular Chemistry 14:3, pages 840-843.
Crossref
Crossref
Chun Wu, Debra Dunaway-Mariano & Patrick S. Mariano. (2012) Design, Synthesis, and Evaluation of Inhibitors of Pyruvate Phosphate Dikinase. The Journal of Organic Chemistry 78:5, pages 1910-1922.
Crossref
Crossref
Chonggang Duan, Jiong Jia, Rongxiu Zhu & Jianwu Wang. (2012)
Synthesis of
N
‐Substituted‐6‐alkoxypteridin‐4‐amine
. Journal of Heterocyclic Chemistry 49:4, pages 865-872.
Crossref
Crossref
John J. Haddad. (2012) The immunopharmacologic potential of Semaxanib and new generation directed therapeutic drugs: Receptor tyrosine kinase regulation with anti-tumorigenensis/angiogenesis properties. Saudi Pharmaceutical Journal 20:2, pages 103-123.
Crossref
Crossref
Savithri Ramurthy, Abran Costales, Johanna M. Jansen, Barry Levine, Paul A. Renhowe, Cynthia M. Shafer & Sharadha Subramanian. (2012) Design and synthesis of 6,6-fused heterocyclic amides as raf kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 22:4, pages 1678-1681.
Crossref
Crossref
Savithri Ramurthy, Mina Aikawa, Payman Amiri, Abran Costales, Ahmad Hashash, Johanna M. Jansen, Song Lin, Sylvia Ma, Paul A. Renhowe, Cynthia M. Shafer, Sharadha Subramanian, Leonard Sung & Joelle Verhagen. (2011) Design and synthesis of 5,6-fused heterocyclic amides as Raf kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 21:11, pages 3286-3289.
Crossref
Crossref
Na Zhang, Rugang Zhong, Hong Yan & Yongjun Jiang. (2011) Structural Features Underlying Selective Inhibition of GSK3β by Dibromocantharelline: Implications for Rational Drug Design. Chemical Biology & Drug Design 77:3, pages 199-205.
Crossref
Crossref
Shana L. Posy, Mark A. Hermsmeier, Wayne Vaccaro, Karl-Heinz Ott, Gordon Todderud, Jonathan S. Lippy, George L. Trainor, Deborah A. Loughney & Stephen R. Johnson. (2010) Trends in Kinase Selectivity: Insights for Target Class-Focused Library Screening. Journal of Medicinal Chemistry 54:1, pages 54-66.
Crossref
Crossref
Vinod R. Hegde, Scott Borges, Haiyan Pu, Mahesh Patel, Vincent P. Gullo, Bonnie Wu, Paul Kirschmeier, Michael J. Williams, Vincent Madison, Thierry Fischmann & Tze-Ming Chan. (2010) Semi-synthetic aristolactams—inhibitors of CDK2 enzyme. Bioorganic & Medicinal Chemistry Letters 20:4, pages 1384-1387.
Crossref
Crossref
Nigus Dessalew & Prasad V. Bharatam. (2007) 3D-QSAR and molecular docking study on bisarylmaleimide series as glycogen synthase kinase 3, cyclin dependent kinase 2 and cyclin dependent kinase 4 inhibitors: An insight into the criteria for selectivity. European Journal of Medicinal Chemistry 42:7, pages 1014-1027.
Crossref
Crossref
Nigus Dessalew & Prasad V. Bharatam. (2007) Identification of potential glycogen kinase-3 inhibitors by structure based virtual screening. Biophysical Chemistry 128:2-3, pages 165-175.
Crossref
Crossref
Li‐Ping Sun, Xiang‐Hong Huang & Jin‐Xin Wang. (2013) A Facile and Efficient Synthesis of 7‐Azaindoles. Journal of the Chinese Chemical Society 54:3, pages 569-573.
Crossref
Crossref
R.V. Stanton & Q. Cao. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
807
818
.
T.K. Sawyer. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
959
992
.
Tomi K. Sawyer. 2007. Cancer. Cancer
383
405
.
Nigus Dessalew, Prasad V. Bharatam & Sanjeev Kumar Singh. (2007) 3D‐QSAR CoMFA Study on Aminothiazole Derivatives as Cyclin‐Dependent Kinase 2 Inhibitors. QSAR & Combinatorial Science 26:1, pages 85-91.
Crossref
Crossref
S.K. Singh, N. Dessalew & P.V. Bharatam. (2006) 3D-QSAR CoMFA study on indenopyrazole derivatives as cyclin dependent kinase 4 (CDK4) and cyclin dependent kinase 2 (CDK2) inhibitors. European Journal of Medicinal Chemistry 41:11, pages 1310-1319.
Crossref
Crossref
Kenneth M. Comess, Jonathan D. Trumbull, Chang Park, Zehan Chen, Russell A. Judge, Martin J. Voorbach, Michael Coen, Lan Gao, Hua Tang, Peter Kovar, Xueheng Cheng, Mark E. Schurdak, Haiying Zhang, Tom Sowin & David J. Burns. (2006) Kinase Drug Discovery by Affinity Selection/Mass Spectrometry (ASMS): Application to DNA Damage Checkpoint Kinase Chk1. SLAS Discovery 11:7, pages 755-764.
Crossref
Crossref
Nigus Dessalew & Prasad V. Bharatam. (2006) Investigation of Potential Glycogen Synthase Kinase 3 Inhibitors Using Pharmacophore Mapping and Virtual Screening. Chemical Biology <html_ent glyph="@amp;" ascii="&"/> Drug Design 68:3, pages 154-165.
Crossref
Crossref
Jörg Degen & Matthias Rarey. (2006) FlexNovo: Structure-Based Searching in Large Fragment Spaces. ChemMedChem 1:8, pages 854-868.
Crossref
Crossref
Santiago Figueroa-Pérez, Samir Bennabi, Hartmut Schirok & Michael Thutewohl. (2006) Efficient synthesis of 4-O- and C-substituted-7-azaindoles. Tetrahedron Letters 47:13, pages 2069-2072.
Crossref
Crossref
Robert J. Chambers, Kristin Abrams, Norman Y. Garceau, Ajith V. Kamath, Christopher M. Manley, Susan C. Lilley, Douglas A. Otte, Dennis O. Scott, Alissa L. Sheils, David A. Tess, A. Samuel Vellekoop, Yan Zhang & Kelvin T. Lam. (2006) A new chemical tool for exploring the physiological function of the PDE2 isozyme. Bioorganic & Medicinal Chemistry Letters 16:2, pages 307-310.
Crossref
Crossref
Pascale Gaillard, Isabelle Jeanclaude-Etter, Vittoria Ardissone, Steve Arkinstall, Yves Cambet, Montserrat Camps, Christian Chabert, Dennis Church, Rocco Cirillo, Denise Gretener, Serge Halazy, Anthony Nichols, Cedric Szyndralewiez, Pierre-Alain Vitte & Jean-Pierre Gotteland. (2005) Design and Synthesis of the First Generation of Novel Potent, Selective, and in Vivo Active (Benzothiazol-2-yl)acetonitrile Inhibitors of the c-Jun N-Terminal Kinase. Journal of Medicinal Chemistry 48:14, pages 4596-4607.
Crossref
Crossref
Justine Y.Q. Lai, Steven Langston, Ruth Adams, Rebekah E. Beevers, Richard Boyce, Svenja Burckhardt, James Cobb, Yvonne Ferguson, Eva Figueroa, Neil Grimster, Andrew H. Henry, Nawaz Khan, Kerry Jenkins, Mark W. Jones, Robert Judkins, Jeremy Major, Abid Masood, James Nally, Helen Payne, Lloyd Payne, Gilles Raphy, Tony Raynham, John Reader, Val�rie Reader, Alison Reid, Parminder Ruprah, Michael Shaw, Hannah Sore, Matthew Stirling, Adam Talbot, Jess Taylor, Stephen Thompson, Hiroki Wada & David Walker. (2005) Preparation of kinase-biased compounds in the search for lead inhibitors of kinase targets. Medicinal Research Reviews 25:3, pages 310-330.
Crossref
Crossref
Marc D. Jacobs, James Black, Olga Futer, Lora Swenson, Brian Hare, Mark Fleming & Kumkum Saxena. (2005) Pim-1 Ligand-bound Structures Reveal the Mechanism of Serine/Threonine Kinase Inhibition by LY294002. Journal of Biological Chemistry 280:14, pages 13728-13734.
Crossref
Crossref
Adrian Gill, Anne Cleasby & Harren Jhoti. (2005) The Discovery of Novel Protein Kinase Inhibitors by Using Fragment-Based High-Throughput X-ray Crystallography. ChemBioChem 6:3, pages 506-512.
Crossref
Crossref
Kazuo Kubo, Toshiyuki Shimizu, Shin-ichi Ohyama, Hideko Murooka, Akemi Iwai, Kazuhide Nakamura, Kazumasa Hasegawa, Yoshiko Kobayashi, Noriko Takahashi, Kazumi Takahashi, Shinichiro Kato, Toshio Izawa & Toshiyuki Isoe. (2005)
Novel Potent Orally Active Selective VEGFR-2 Tyrosine Kinase Inhibitors: Synthesis, Structure−Activity Relationships, and Antitumor Activities of
N
-Phenyl-
N
‘-{4-(4-quinolyloxy)phenyl}ureas
. Journal of Medicinal Chemistry 48:5, pages 1359-1366.
Crossref
Crossref
Stanley F. BARNETTDeborah DEFEO-JONESSheng FUPaula J. HANCOCKKathleen M. HASKELLRaymond E. JONESJason A. KAHANAAstrid M. KRALKaren LEANDERLing L. LEEJohn MALINOWSKIElizabeth M. McAVOYDebbie D. NAHASRonald G. ROBINSONHans E. HUBER. (2005) Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors. Biochemical Journal 385:2, pages 399-408.
Crossref
Crossref
L. Meijer, M. Leost, O. Lozach, S. Schmitt & C. Kunick. 2005. Inhibitors of Protein Kinases and Protein Phosphates. Inhibitors of Protein Kinases and Protein Phosphates
47
64
.
T. K. Sawyer, R. S. Bohacek, W. C. Shakespeare, C. A. MetcalfIIIIII, Y. Wang, R. Sundaramoorthi, T. Keenan, S. Narula & D. C. Dalgarno. 2005. Proteomics and Protein-Protein Interactions. Proteomics and Protein-Protein Interactions
219
253
.
Thomas Rückle, Marco Biamonte, Tania Grippi-Vallotton, Steve Arkinstall, Yves Cambet, Montserrat Camps, Christian Chabert, Dennis J. Church, Serge Halazy, Xuliang Jiang, Isabelle Martinou, Anthony Nichols, Wolfgang Sauer & Jean-Pierre Gotteland. (2004) Design, Synthesis, and Biological Activity of Novel, Potent, and Selective (Benzoylaminomethyl)thiophene Sulfonamide Inhibitors of c-Jun-N-Terminal Kinase. Journal of Medicinal Chemistry 47:27, pages 6921-6934.
Crossref
Crossref
Alex M. Aronov & Guy W. Bemis. (2004) A minimalist approach to fragment-based ligand design using common rings and linkers: Application to kinase inhibitors. Proteins: Structure, Function, and Bioinformatics 57:1, pages 36-50.
Crossref
Crossref
Xiaoyang Xia, Edward G. Maliski, Paul Gallant & David Rogers. (2004) Classification of Kinase Inhibitors Using a Bayesian Model. Journal of Medicinal Chemistry 47:18, pages 4463-4470.
Crossref
Crossref
Shenliang Wang, Tae Bo Sim, Yang-Suk Kim & Young-Tae Chang. (2004) Tools for target identification and validation. Current Opinion in Chemical Biology 8:4, pages 371-377.
Crossref
Crossref
John T. Hunt, Toomas Mitt, Robert Borzilleri, Johnni Gullo-Brown, Joseph Fargnoli, Brian Fink, Wen-Ching Han, Steven Mortillo, Gregory Vite, Barri Wautlet, Tai Wong, Chiang Yu, Xiaoping Zheng & Rajeev Bhide. (2004)
Discovery of the Pyrrolo[2,1-
f
][1,2,4]triazine Nucleus as a New Kinase Inhibitor Template
. Journal of Medicinal Chemistry 47:16, pages 4054-4059.
Crossref
Crossref
Marie Gompel, Maryse Leost, Elisa Bal De Kier Joffe, Lydia Puricelli, Laura Hernandez Franco, Jorge Palermo & Laurent Meijer. (2004) Meridianins, a new family of protein kinase inhibitors isolated from the Ascidian Aplidium meridianum. Bioorganic & Medicinal Chemistry Letters 14:7, pages 1703-1707.
Crossref
Crossref
Panagiotis PolychronopoulosProkopios MagiatisAlexios-Leandros SkaltsounisVassilios MyrianthopoulosEmmanuel MikrosAldo TarriconeAndrea MusacchioS. Mark RoeLaurence PearlMaryse LeostPaul GreengardLaurent Meijer. (2004) Structural Basis for the Synthesis of Indirubins as Potent and Selective Inhibitors of Glycogen Synthase Kinase-3 and Cyclin-Dependent Kinases. Journal of Medicinal Chemistry 47:4, pages 935-946.
Crossref
Crossref
Uday R. Khire, Donald Bankston, James Barbosa, David R. Brittelli, Yolanda Caringal, Robert Carlson, Jacques Dumas, Todd Gane, Sarah L. Heald, Barbara Hibner, Jeffrey S. Johnson, Michael E. Katz, Nancy Kennure, Jill Kingery-Wood, Wendy Lee, Xiao-Gao Liu, Timothy B. Lowinger, Ian McAlexander, Mary-Katherine Monahan, Reina Natero, Joel Renick, Bernd Riedl, Hong Rong, Robert N. Sibley, Roger A. Smith & Donald Wolanin. (2004) Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 14:3, pages 783-786.
Crossref
Crossref
Kazuo Kubo, Shin-ichi Ohyama, Toshiyuki Shimizu, Atsuya Takami, Hideko Murooka, Tsuyoshi Nishitoba, Shinichiro Kato, Mikio Yagi, Yoshiko Kobayashi, Noriko Iinuma, Toshiyuki Isoe, Kazuhide Nakamura, Hiroshi Iijima, Tatsushi Osawa & Toshio Izawa. (2003) Synthesis and structure–activity relationship for new series of 4-Phenoxyquinoline derivatives as specific inhibitors of platelet-derived growth factor receptor tyrosine kinase. Bioorganic & Medicinal Chemistry 11:23, pages 5117-5133.
Crossref
Crossref
Rachel R. KroeJohn ReganAl ProtoGregory W. PeetTapon RoyLaura D. LandroNatalie G. FuschettoChristopher A. PargellisRichard H. Ingraham. (2003) Thermal Denaturation: A Method to Rank Slow Binding, High-Affinity P38α MAP Kinase Inhibitors. Journal of Medicinal Chemistry 46:22, pages 4669-4675.
Crossref
Crossref
Giovanna Scapin, Sangita B. Patel, JeanMarie Lisnock, Joseph W. Becker & Philip V. LoGrasso. (2003) The Structure of JNK3 in Complex with Small Molecule Inhibitors. Chemistry & Biology 10:8, pages 705-712.
Crossref
Crossref
Anthony M. Manning & Roger J. Davis. (2003) Targeting JNK for therapeutic benefit: from junk to gold?. Nature Reviews Drug Discovery 2:7, pages 554-565.
Crossref
Crossref
Yvette Mettey, Marie Gompel, Virginie Thomas, Matthieu Garnier, Maryse Leost, Irène Ceballos-Picot, Martin Noble, Jane Endicott, Jean-michel Vierfond & Laurent Meijer. (2002) Aloisines, a New Family of CDK/GSK-3 Inhibitors. SAR Study, Crystal Structure in Complex with CDK2, Enzyme Selectivity, and Cellular Effects. Journal of Medicinal Chemistry 46:2, pages 222-236.
Crossref
Crossref
A. L. Hopkins & C. R. Groom. 2003. Small Molecule — Protein Interactions. Small Molecule — Protein Interactions
11
17
.
Colin R Groom & Andrew L Hopkins. (2002) Protein kinase drugs – optimism doesn't wait on facts ▾. Drug Discovery Today 7:15, pages 801-802.
Crossref
Crossref
Marie Knockaert, Karen Wieking, Sophie Schmitt, Maryse Leost, Karen M. Grant, Jeremy C. Mottram, Conrad Kunick & Laurent Meijer. (2002) Intracellular Targets of Paullones. Journal of Biological Chemistry 277:28, pages 25493-25501.
Crossref
Crossref
John Regan, Steffen Breitfelder, Pier Cirillo, Thomas Gilmore, Anne G. Graham, Eugene Hickey, Bernhard Klaus, Jeffrey Madwed, Monica Moriak, Neil Moss, Chris Pargellis, Sue Pav, Alfred Proto, Alan Swinamer, Liang Tong & Carol Torcellini. (2002) Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate. Journal of Medicinal Chemistry 45:14, pages 2994-3008.
Crossref
Crossref
Giovanna Scapin. (2002) Structural biology in drug design: selective protein kinase inhibitors. Drug Discovery Today 7:11, pages 601-611.
Crossref
Crossref
Yadagiri Bathini, Inderjit Sidhu, Rajeshwar Singh, Ronald G. Micetich & Peter L. Toogood. (2002) Synthesis of substituted quinazolines. Tetrahedron Letters 43:18, pages 3295-3296.
Crossref
Crossref
Roger A Smith, James Barbosa, Cheri L Blum, Mark A Bobko, Yolanda V Caringal, Robert Dally, Jeffrey S Johnson, Michael E Katz, Nancy Kennure, Jill Kingery-Wood, Wendy Lee, Timothy B Lowinger, John Lyons, Vivienne Marsh, Daniel H Rogers, Stephen Swartz, Tracy Walling & Hanno Wild. (2001) Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach. Bioorganic & Medicinal Chemistry Letters 11:20, pages 2775-2778.
Crossref
Crossref
Alexander J. Bridges. (2001) Chemical Inhibitors of Protein Kinases. Chemical Reviews 101:8, pages 2541-2572.
Crossref
Crossref
S.David Kimball & Kevin R. Webster. 2001.
139
148
.